Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc A Judson

Showing results (191-200 of 277) with videos related to

Pageof 28
Sort By:
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 8, 2021
Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trialRobert P Baughman, Marc A Judson, Daniel A Culver, et al.
Annals of the American Thoracic Society|August 11, 2016
Sarcoidosis in America. Analysis Based on Health Care UseRobert P Baughman, Shelli Field, Ulrich Costabel, et al.
Chest|March 21, 2020
Diagnostic Accuracy of Thoracic Ultrasonography to Differentiate Transudative From Exudative Pleural EffusionBoris Shkolnik, Marc A Judson, Adam Austin, et al.
Chest|October 10, 2020
ResponseBoris Shkolnik, Marc A Judson, Adam Austin, et al.
Respiratory Medicine|May 16, 2021
Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI)Ogugua Ndili Obi, Marc A Judson, Surinder S Birring, et al.
Respiratory Medicine|May 27, 2019
Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosisMarc A Judson, Sara Preston, Kurt Hu, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 31, 2002
Use of fluticasone in acute symptomatic pulmonary sarcoidosisRobert P Baughman, Michael C Iannuzzi, Elyse E Lower, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|September 19, 2022
Value of pulmonary function testing identifying progressive pulmonary disease in fibrotic sarcoidosis: results of a prospective feasibility studyRobert P Baughman, Rohit Gupta, Marc A Judson, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 10, 2018
High frequency ultrasound: a novel instrument to quantify granuloma burden in cutaneous sarcoidosisMegan H Noe, Olaf Rodriguez, Laura Taylor, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 6, 2016
Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trialRobert P Baughman, Marc A Judson, Elyse E Lower, et al.
Pageof 28

Showing results (191-200 of 277) with videos related to

Sort By:
Pageof 28
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 8, 2021
Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trialRobert P Baughman, Marc A Judson, Daniel A Culver, et al.
Annals of the American Thoracic Society|August 11, 2016
Sarcoidosis in America. Analysis Based on Health Care UseRobert P Baughman, Shelli Field, Ulrich Costabel, et al.
Chest|March 21, 2020
Diagnostic Accuracy of Thoracic Ultrasonography to Differentiate Transudative From Exudative Pleural EffusionBoris Shkolnik, Marc A Judson, Adam Austin, et al.
Chest|October 10, 2020
ResponseBoris Shkolnik, Marc A Judson, Adam Austin, et al.
Respiratory Medicine|May 16, 2021
Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI)Ogugua Ndili Obi, Marc A Judson, Surinder S Birring, et al.
Respiratory Medicine|May 27, 2019
Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosisMarc A Judson, Sara Preston, Kurt Hu, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 31, 2002
Use of fluticasone in acute symptomatic pulmonary sarcoidosisRobert P Baughman, Michael C Iannuzzi, Elyse E Lower, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|September 19, 2022
Value of pulmonary function testing identifying progressive pulmonary disease in fibrotic sarcoidosis: results of a prospective feasibility studyRobert P Baughman, Rohit Gupta, Marc A Judson, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 10, 2018
High frequency ultrasound: a novel instrument to quantify granuloma burden in cutaneous sarcoidosisMegan H Noe, Olaf Rodriguez, Laura Taylor, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 6, 2016
Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trialRobert P Baughman, Marc A Judson, Elyse E Lower, et al.
Pageof 28